Fibroid tumors

Also found in: Dictionary, Thesaurus, Encyclopedia.

Fibroid tumors

Fibroid tumors are non-cancerous (benign) growths in the uterus. They occur in 30-40% of women over age 40, and do not need to be removed unless they are causing symptoms that interfere with a woman's normal activities.

Patient discussion about Fibroid tumors

Q. uterine fibroids. Whats the best way to deal with them? My doctor says hysterectomy? What about my hormones?

A. Yes, drugs that suppress the levels of the female sex hormones (estrogen) are successful for treating uterine fibroids. However, the relief is only temporary and the fibroids recur once the treatment is stopped. In addition, these treatments cause side effects similar to menopause.

Surgery is the definitive treatment, especially for complications such as bleeding or pain, and when there's a suspicion for malignancy.

You may read more here:

More discussions about Fibroid tumors
References in periodicals archive ?
The variation in relative amounts of IGF-I mRNA reported in these studies may have been due to the heterogeneity that exists among fibroid tumors (Rein and Nowak 1992).
The new technology uses highly focused ultrasound to ablate, or break down, fibroid tumors.
Uterine fibroid embolization (UFE) is a minimally invasive interventional radiology treatment that blocks the blood supply to the fibroid tumors, causing them to shrink and die, alleviating symptoms.
She pioneered the use of women's self-care treatments based on diet, nutrition, exercise and stress management, and has penned a number of books, including Fibroid Tumors & Endometriosis and the Estrogen Decision.
The first tranche has already been completed, and the second tranche is conditioned on the approval of the US Food and Drug Administration of InSightec's focused ultrasound technology for the treatment of uterine fibroid tumors.
WASHINGTON, April 19 /PRNewswire/ -- Lycopene, the antioxidant found in tomatoes that gives them their red color, may be able to reduce the size and incidence of fibroid tumors based on an animal study presented today at the annual Experimental Biology meeting being held here this week.
NASDAQ: BMED), can help reduce the number of hysterectomies in women suffering from benign uterine fibroid tumors and provide less invasive, less costly alternatives for women requiring other types of gynecological surgery.
PHOENIX, March 26 /PRNewswire/ -- The first large, multi-center, comparative trial shows that uterine fibroid embolization -- a minimally invasive interventional radiology treatment that blocks the blood supply to the fibroid tumors, causing them to shrink -- offers a much quicker recovery and a lower adverse event rate compared to myomectomy, the surgical removal of uterine fibroids.
These include excessive menstrual bleeding, cancer, nonmalignant fibroid tumors and endometriosis, an inflammation of the lining of the uterus.
The FDA's approval of mifepristone also clears a path for long-stalled trials of mifepristone's other possible beneficial applications in treating uterine fibroid tumors, ovarian cancer, endometriosis, and meningioma (brain tumors).
The study is being conducted at two clinical sites in Europe, and will include up to 50 patients undergoing surgery for removal of uterine fibroid tumors (myomectomy).